Deveau C - Search Results

1

Thrombocytopenia during primary HIV-1 infection predicts the risk of recurrence during chronic infection.

Ghosn J, Persoz A, Zitoun Y, Chaix ML, Amri I, Reynes J, Raffi F, Deveau C, Meyer L, Goujard C; ANRS CO6 PRIMO Cohort. Ghosn J, et al. Among authors: deveau c. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):e112-4. doi: 10.1097/QAI.0b013e31825b6fde. J Acquir Immune Defic Syndr. 2012. PMID: 22772349 No abstract available.

2

French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.

Descamps D, Chaix ML, André P, Brodard V, Cottalorda J, Deveau C, Harzic M, Ingrand D, Izopet J, Kohli E, Masquelier B, Mouajjah S, Palmer P, Pellegrin I, Plantier JC, Poggi C, Rogez S, Ruffault A, Schneider V, Signori-Schmück A, Tamalet C, Wirden M, Rouzioux C, Brun-Vezinet F, Meyer L, Costagliola D. Descamps D, et al. Among authors: deveau c. J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):545-52. doi: 10.1097/01.qai.0000155201.51232.2e. J Acquir Immune Defic Syndr. 2005. PMID: 15793364

3

Temporary employment, absence of stable partnership, and risk of hospitalization or death during the course of HIV infection.

Dray-Spira R, Gueguen A, Persoz A, Deveau C, Lert F, Delfraissy JF, Meyer L; PRIMO Cohort Study Group. Dray-Spira R, et al. Among authors: deveau c. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):190-7. doi: 10.1097/01.qai.0000165908.12333.4e. J Acquir Immune Defic Syndr. 2005. PMID: 16186737

4

Rapid CD4+ cell decrease after transient cART initiated during primary HIV infection (ANRS PRIMO and SEROCO cohorts).

Seng R, Goujard C, Desquilbet L, Sinet M, Rouzioux C, Deveau C, Boufassa F, Delfraissy JF, Meyer L, Venet A; ANRS PRIMO and SEROCO Study Groups. Seng R, et al. Among authors: deveau c. J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):251-8. doi: 10.1097/QAI.0b013e318189a739. J Acquir Immune Defic Syndr. 2008. PMID: 18845951

5

Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.

Ghosn J, Deveau C, Chaix ML, Goujard C, Galimand J, Zitoun Y, Allègre T, Delfraissy JF, Meyer L, Rouzioux C; ANRS PRIMO Cohort. Ghosn J, et al. Among authors: deveau c. J Antimicrob Chemother. 2010 Apr;65(4):741-8. doi: 10.1093/jac/dkq035. Epub 2010 Feb 18. J Antimicrob Chemother. 2010. PMID: 20167586

6

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.

Ghosn J, Pellegrin I, Goujard C, Deveau C, Viard JP, Galimand J, Harzic M, Tamalet C, Meyer L, Rouzioux C, Chaix ML; French PRIMO Cohort Study Group (ANRS CO 06). Ghosn J, et al. Among authors: deveau c. AIDS. 2006 Jan 9;20(2):159-70. doi: 10.1097/01.aids.0000199820.47703.a0. AIDS. 2006. PMID: 16511408

7

High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.

Frange P, Galimand J, Goujard C, Deveau C, Ghosn J, Rouzioux C, Meyer L, Chaix ML. Frange P, et al. Among authors: deveau c. J Antimicrob Chemother. 2009 Jul;64(1):135-41. doi: 10.1093/jac/dkp151. Epub 2009 May 2. J Antimicrob Chemother. 2009. PMID: 19411680

8

Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Goujard C, Chaix ML, Lambotte O, Deveau C, Sinet M, Guergnon J, Courgnaud V, Rouzioux C, Delfraissy JF, Venet A, Meyer L; Agence Nationale de Recherche sur le Sida PRIMO Study Group. Goujard C, et al. Among authors: deveau c. Clin Infect Dis. 2009 Sep 15;49(6):982-6. doi: 10.1086/605504. Clin Infect Dis. 2009. PMID: 19681706

9

Undetectable HIV-1 RNA load with the Cobas TaqMan v1.0 in a patient diagnosed at the time of primary HIV-1 infection.

Ghosn J, Galimand J, Meyer L, Descamps D, Vabret A, Deveau C, Yéni P, Goujard C, Rouzioux C, Chaix ML; French ANRS CO06 PRIMO Cohort. Ghosn J, et al. Among authors: deveau c. J Med Virol. 2010 Nov;82(11):1816-8. doi: 10.1002/jmv.21827. J Med Virol. 2010. PMID: 20872706

10

HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.

Goujard C, Girault I, Rouzioux C, Lécuroux C, Deveau C, Chaix ML, Jacomet C, Talamali A, Delfraissy JF, Venet A, Meyer L, Sinet M; ANRS CO6 PRIMO Study Group. Goujard C, et al. Among authors: deveau c. Antivir Ther. 2012;17(6):1001-9. doi: 10.3851/IMP2273. Epub 2012 Aug 6. Antivir Ther. 2012. PMID: 22865544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters